| |
| |
|
| Insider
Information: |
Wade Jeffrey L |
| Relationship: |
President and CFO |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
324,214 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$499,290 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
324,214 |
|
|
| Total
Value |
$499,290 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 14.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
President and CFO |
2024-02-28 |
324,214 |
2009-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2024-02-28 |
4 |
D |
$2.62 |
$98,750 |
D/D |
(37,691) |
324,214 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
97,564 |
361,905 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2023-09-14 |
4 |
B |
$1.38 |
$13,800 |
D/D |
10,000 |
264,341 |
2.74 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2023-02-28 |
4 |
D |
$2.17 |
$65,653 |
D/D |
(30,255) |
242,341 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
78,916 |
272,596 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2022-02-28 |
4 |
D |
$2.85 |
$73,453 |
D/D |
(25,773) |
193,680 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CFO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
66,933 |
219,453 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,109 |
183,604 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2021-02-28 |
4 |
D |
$7.19 |
$191,139 |
D/D |
(26,584) |
157,020 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$18,916 |
D/D |
(9,651) |
115,495 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
26,525 |
125,146 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$44,389 |
D/D |
(16,025) |
98,621 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,138 |
114,646 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2019-02-28 |
4 |
D |
$5.51 |
$47,601 |
D/D |
(8,639) |
72,508 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,655 |
81,147 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$52,314 |
D/D |
(6,133) |
59,492 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,028 |
65,625 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-11-14 |
4 |
B |
$9.48 |
$18,962 |
D/D |
2,000 |
50,597 |
2.74 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-02-28 |
4 |
D |
$16.45 |
$106,185 |
D/D |
(6,455) |
48,597 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,659 |
55,052 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2016-02-29 |
4 |
D |
$9.07 |
$34,602 |
D/D |
(3,815) |
39,393 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,949 |
43,208 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$19,475 |
D/D |
(20,718) |
204,821 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,750 |
225,539 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,250 |
166,086 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
